CardioComm Solutions (CVE:EKG) Sets New 1-Year Low at $0.04

Share on StockTwits

Shares of CardioComm Solutions Inc (CVE:EKG) hit a new 52-week low during trading on Wednesday . The company traded as low as C$0.04 and last traded at C$0.04, with a volume of 100000 shares traded. The stock had previously closed at C$0.04.

The stock’s 50-day moving average price is C$0.04 and its 200 day moving average price is C$0.05. The firm has a market cap of $5.63 million and a P/E ratio of -8.75. The company has a debt-to-equity ratio of 430.31, a current ratio of 0.84 and a quick ratio of 0.65.

About CardioComm Solutions (CVE:EKG)

CardioComm Solutions, Inc, together with its subsidiary, CardioView Inc, develops software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. Its technology is used in a range of products for the recording, transmission, viewing, analyzing, reporting, and storage of ECGs for arrhythmia screening, diagnosis, and management of cardiac patients.

Recommended Story: New Google Finance Tool and Screening Stocks

Receive News & Ratings for CardioComm Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioComm Solutions and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

DATA  Price Hits $0.0003 on Top Exchanges
DATA Price Hits $0.0003 on Top Exchanges
Bloom  Achieves Market Capitalization of $1.25 Million
Bloom Achieves Market Capitalization of $1.25 Million
BTU Protocol Price Tops $0.14
BTU Protocol Price Tops $0.14
$0.33 EPS Expected for Enphase Energy Inc  This Quarter
$0.33 EPS Expected for Enphase Energy Inc This Quarter
Zacks: Brokerages Anticipate Parsley Energy Inc  to Post $0.35 Earnings Per Share
Zacks: Brokerages Anticipate Parsley Energy Inc to Post $0.35 Earnings Per Share
-$0.62 Earnings Per Share Expected for Heron Therapeutics Inc  This Quarter
-$0.62 Earnings Per Share Expected for Heron Therapeutics Inc This Quarter


© 2006-2019 Ticker Report